Axsome Therapeutics, Inc. (AXSM) NASDAQ

173.28

-1.05(-0.60%)

Updated at January 14 09:47AM

Currency In USD

Valuation

Market Cap4.05B
Enterprise Value3.93B
P/E Ratio-37.99
PEG Ratio-4.82
Price/Sales Ratio15.66
Price/Book Ratio118.28
Enterprise/Revenue15.47
Enterprise/EBITDA-40.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.41
Operating Margin-0.38

Management Effectiveness

Return On Assets-0.34
Return On Equity-3.57

Income Statement

Revenue385.69M
Revenue/Share11.22
Gross Profit352.39M
EBITDA-272.6M
Net Income-287.22M
Diluted EPS-5.99

Balance Sheet

Total Cash325.27M
Total Cash/Share6.5
Total Debt218.6M
Total Debt/Equity2.96
Current Ratio1.57
Book Value Per Share1.47

Price History

52-Week Change106.06
52-Week High184.4
52-Week Low86.07
Moving Average 50 Days150.06
Moving Average 200 Days121.36

Statistics

Average Volume619,506
Shares Outstanding50.41M
% Held by Institutions75.2

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A